WASHINGTONMedtronic Inc undeterred by a surprising and definitive clinicaltrial failure said it will continue to develop its medical device for high blood pressure in hopes of winning US regulatory approval The company shocked doctors and industry rivals in January when it said that its device used to singe nerves in the kidneys with low levels of radiofrequency energy had failed in a large clinical trial to lower patients blood pressure more effectively than a placebo or sham procedure